Trotti, A., Belim, L.A., Epstein, J.B., et al. (2003) Mucositis Incidence, Severity, and Associated Outcomes in Patients with Head and Neck Cancer Receiving Radiotherapy with or without Chemotherapy: A Systematic Literature Review. Radiotherapy and Oncology, 66, 253-262.
https://doi.org/10.1016/S0167-8140(02)00404-8

has been cited by the following article:

• TITLE: Supersaturated Calcium Phosphate Rinse vs. Standard of Care for Mitigating Mucositis in Head and Neck Chemoradiation

  AUTHORS: Justin Brock, Chris Morris, Kathleen Hotze, Brian Pikkula

  KEYWORDS: Oral Mucositis, Health Care Cost, WHO OM Scale

  JOURNAL NAME: Journal of Cancer Therapy, Vol.9 No.3, March 14, 2018

  ABSTRACT: Introduction: Oral mucositis (OM) can have a significant impact on patients’ quality of life, pain and treatment costs. Almost all patients receiving head and neck chemoradiation develop OM. Patients and Methods: Twenty patients were evaluated retrospectively for OM when undergoing head and neck chemoradiation. The control, soda/salt rinse, was compared to a powdered supersaturated calcium phosphate rinse (SSCPR), SalivaMAX. Results: The SSCPR group experienced a delay in the onset of OM, which was not statistically significant, and a marked reduction in peak OM that was statistically significant (p > 0.001). Conclusion: This retrospective study demonstrates that a powdered SSCPR is a safe and effective method of oral mucositis mitigation.